Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

DPH.L News

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM
13 Jan 2022

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM

Dechra sees full year at upper end of management expectations
13 Jan 2022

Dechra sees full year at upper end of management expectations

(Sharecast News) - Dechra Pharmaceuticals said on Thursday that the full-year outlook was towards the upper end of management expectations as it repor...

Dechra acquires worldwide rights to canine lymphoma treatment
11 Jan 2022

Dechra acquires worldwide rights to canine lymphoma treatment

(Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine ly...

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing
11 Jan 2022

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook
11 Jan 2022

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug
11 Jan 2022

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises
11 Jan 2022

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises

Dechra slumps as Exane highlights 'punchy valuation'
4 Jan 2022

Dechra slumps as Exane highlights 'punchy valuation'

(Sharecast News) - Dechra Pharmaceuticals was under the cosh on Tuesday after Exane BNP Paribas initiated coverage of the stock at 'neutral' on valuat...